Claims Analysis
Total Claims: 20
Claim 1
Independent Claim
50 words
A method of treatment of emesis, anxiety and/or IBS in mammals, which method comprises administering to a mammal in need of such treatment an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof: Ar--CO--Y--I (I) wherein Ar is a group of formula (a): ##STR23## wherein:
Claim 2
Independent Claim
50 words
A method of treatment of emesis, anxiety and/or IBS in mammals, which method comprises administering to a mammal in need of such treatment an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof: Ar--CO--Y--I (I) wherein Ar is a group of formula (a): ##STR23## wherein:
Claim 3
Dependent Claim
132 words
R 1 and R 2 are independently selected from hydrogen, halogen, C 1-6 alkyl, C 1-4 alkoxy, hydroxy, amino optionally substituted by one or two C 1-4 alkyl groups, thiol, C 1-4 alkylthio; X is CH 2 , NR 3 , --O-- or --S-- wherein R 3 is hydrogen C 1-4 alkyl, C 3-5 alkenyl, phenyl or phenyl C 1-4 alkyl; Y --O-- or --NH--; and Z is a group of formula (c), (d) or (e): ##STR24## wherein n is 2, 3 or 4; R 8 is hydrogen, C 1-7 alkyl, C 3-5 alkenyl or phenyl C 1-4 alkyl optionally substituted by one or two halogen, C 1-4 alkoxy or C 1-4 alkyl; ##STR25## wherein: P is 1, 2, or 3; and R 9 is as defined above for R 8 .
Claim 4
Dependent Claim
132 words
R 1 and R 2 are independently selected from hydrogen, halogen, C 1-6 alkyl, C 1-4 alkoxy, hydroxy, amino optionally substituted by one or two C 1-4 alkyl groups, thiol, C 1-4 alkylthio; X is CH 2 , NR 3 , --O-- or --S-- wherein R 3 is hydrogen C 1-4 alkyl, C 3-5 alkenyl, phenyl or phenyl C 1-4 alkyl; Y --O-- or --NH--; and Z is a group of formula (c), (d) or (e): ##STR24## wherein n is 2, 3 or 4; R 8 is hydrogen, C 1-7 alkyl, C 3-5 alkenyl or phenyl C 1-4 alkyl optionally substituted by one or two halogen, C 1-4 alkoxy or C 1-4 alkyl; ##STR25## wherein: P is 1, 2, or 3; and R 9 is as defined above for R 8 .
Claim 5
Dependent Claim
28 words
A method according to claim 1 wherein the compound is of formula (I), Ar is of formula (a), and X is NR 3 as defined in claim 1.
Claim 6
Dependent Claim
43 words
A method according to claim 1 wherein the compound is of formula (IA): ##STR26## wherein Z 1 is a group of formula (c) as defined in claim 1 and R 1 , R 3 , and Y are as defined in claim 1.
Claim 7
Dependent Claim
37 words
A method according to claim 1 wherein the compound is of formula (IE): ##STR27## wherein Z 3 is a group of formula (e) and R 1 , R 3 and Y are as defined in claim 1.
Claim 8
Dependent Claim
16 words
A method according to claim 3 wherein R 8 or R 9 is methyl or ethyl.
Claim 9
Dependent Claim
24 words
A method according to claim 1 wherein the compound of formula (I) is selected from the group consisting of: 3,5-dichloro-[3α-(8-methyl-8-azabicyclo(3.2.1 )octyl)]-benzoate, indole-[3α(8-methyl-8-azabicyclo(3.2.1)octyl)]-3-carboxylate, 3,5-dimethyl-[3α-(8-methyl-8-azabicyclo(3.2.1)octyl)]-benzoate, indole-[5-(2-methyl-2-azabicyclo(2.2.2)octyl)]-3-carboxylate,
Claim 10
Dependent Claim
11 words
2,3,9-tetrahydro-9-metyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one, or a pharmaceutically acceptable salt of any of the foregoing.
Claim 11
Dependent Claim
11 words
2,3,9-tetrahydro-9-metyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one, or a pharmaceutically acceptable salt of any of the foregoing.
Claim 12
Dependent Claim
16 words
A method according to claim 4 wherein R 8 or R 9 is methyl or ethyl.
Claim 13
Dependent Claim
11 words
A method according to claim 1 wherein said mammals are humans.
Claim 14
Independent Claim
28 words
A method of tretatment of emesis, anxiety and/or IBS in mammals, which method comprises administering to a mammal in need of such treatment an effective amount of Indole-[3-(methyl-8-azabicyclo(3.2.1)octyl)]-3-carboxylate.
Claim 15
Independent Claim
28 words
A method of tretatment of emesis, anxiety and/or IBS in mammals, which method comprises administering to a mammal in need of such treatment an effective amount of Indole-[3-(methyl-8-azabicyclo(3.2.1)octyl)]-3-carboxylate.
Claim 16
Independent Claim
30 words
A method of treatment of cytotoxic agent induced nausea and vomiting, which method comprises administering to a mammal in need of such treatment an effective amount of Indole-[3-(methyl-8-azabicylclo (3.2.1) octyl)]-3-carboxylate.
Claim 17
Independent Claim
30 words
A method of treatment of cytotoxic agent induced nausea and vomiting, which method comprises administering to a mammal in need of such treatment an effective amount of Indole-[3-(methyl-8-azabicylclo (3.2.1) octyl)]-3-carboxylate.
Claim 18
Independent Claim
26 words
A method of treatment of radiation agent induced nausea and vomiting, administering to a mammal in need of such treatment an effective amount of Indole-[3-(methyl-8-azabicyclo(3.2.1 )octyl)]-3-carboxylate.
Claim 19
Independent Claim
26 words
A method of treatment of radiation agent induced nausea and vomiting, administering to a mammal in need of such treatment an effective amount of Indole-[3-(methyl-8-azabicyclo(3.2.1 )octyl)]-3-carboxylate.
Claim 20
Dependent Claim
17 words
A method according to claim 11 wherein the cytotoxic agent is selected from cisplatin, doxorubicin and cyclophosphamide.